SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $343,780 | -92.3% | 2,836 | -92.7% | 0.00% | -93.3% |
| Q2 2023 | $4,470,403 | +435.2% | 39,036 | +544.2% | 0.06% | +400.0% |
| Q1 2023 | $835,250 | -15.2% | 6,060 | -20.3% | 0.01% | -20.0% |
| Q4 2022 | $985,197 | +109.0% | 7,603 | -10.7% | 0.02% | +200.0% |
| Q3 2022 | $471,471 | +32.8% | 8,514 | +86.5% | 0.01% | +66.7% |
| Q2 2021 | $355,000 | +4.1% | 4,565 | -0.2% | 0.00% | -25.0% |
| Q1 2021 | $341,000 | -99.2% | 4,572 | -98.3% | 0.00% | -99.0% |
| Q4 2020 | $44,770,000 | +104.3% | 262,600 | +68.3% | 0.39% | -10.5% |
| Q3 2020 | $21,917,000 | +2837.9% | 156,076 | +2600.7% | 0.44% | +3028.6% |
| Q4 2019 | $746,000 | -16.4% | 5,779 | -22.8% | 0.01% | -60.0% |
| Q1 2019 | $892,000 | -16.9% | 7,482 | +12.6% | 0.04% | -7.9% |
| Q3 2018 | $1,073,000 | +158.6% | 6,646 | +111.7% | 0.04% | +52.0% |
| Q2 2018 | $415,000 | – | 3,140 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |